Search Results

COMPLETE SE and Other SFA Trials

A look at the ongoing trials of self-expanding stents in the superficial femoral artery.

By Khung Keong Yeo, MD, and John R. Laird Jr, MD

Lessons Learned in RESILIENT

Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.

Remote Endarterectomy Update

An endovascular alternative to bypass?

By John D. Martin, MD

Venous Center Accreditation

A pathway to improved quality of care.

By John Blebea, MD, MBA

Interventional Strategies for Atherosclerotic Popliteal Disease

A review of the limitations and therapeutic options available for treating this challenging segment.

By John H. Rundback, MD, and Luis Rodriguez, Jr, MD

The Decade in Vascular Trauma

The developments and data that have shaped modern vascular trauma care and what the next decade may hold.

By John Fritz Angle, MD, and James Forrest Calland, MD

Overview of Restenosis in Peripheral Arterial Interventions

Restenosis continues to complicate percutaneous procedures, but new treatments hold promise.

By Robert S. Dieter, MD, RVT, and John R. Laird, Jr, MD

Nonstent Endovascular Treatment of SFA Occlusions

High failure rates of balloon angioplasty and stent fracture suggest a need for nonstent alternatives.

By Robert S. Dieter, MD, RVT, and John R. Laird, Jr, MD

Randomized Trials and Registries of Superficial Femoral Artery Stenting

The current data and future directions of SFA stenting technology.

By Ehrin J. Armstrong, MD, John R. Laird, MD

Fungal Aortic Endograft Infection

Increasing application of EVAR and adjunctive procedures for endoleak repair may increase the incidence of this complication.

By Rashad G. Choudry, MD; Kathleen M. Lamb, BS; John Blebea, MD; Tejwant Datta, MD; and H. Hank Simms, MD

Unique Approach to CLI in a Recurrent Aortofemoral Limb Failure Patient

Moderator: Tony S. Das, MD, FACC
Panel: George L. Adams, MD, MHS, MBA; John H. Rundback, MD; and Miguel Montero-Baker, MD

SFA Trials, Devices, and Decisions

An expert panel provides candid perspectives on issues facing current clinical trials and the regulatory environment, adopting new technologies, and daily decision making in busy peripheral practices.
Featuring Gary M. Ansel, MD, FACC; Michael D. Dake, MD; Lawrence A. Garcia, MD; John R. Laird, MD; and Peter A. Schneider, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Training in Dialysis Access: Where to Get It and Why We Need It

Society meetings, live conferences, simulated training, and online resources are invaluable tools for patient-centered and value-based care.

By Therese A. Wykoff, MS; Gerald Beathard, MD, PhD; Ingemar Davidson, MD, PhD; Bart Dolmatch, MD, FSIR; Maurizio Gallieni, MD; Nicholas Inston, MD, PhD; Ngoh Chin Liew, MD; Richard F. Neville, MD, FACS; Billy Nolen, Captain; John Ross, MD; and Douglas Slakey, MD